MFAP5
Basic information
Region (hg38): 12:8637346-8662888
Links
Phenotypes
GenCC
Source:
- aortic aneurysm, familial thoracic 9 (Moderate), mode of inheritance: AD
- aortic aneurysm, familial thoracic 9 (Limited), mode of inheritance: AD
- familial thoracic aortic aneurysm and aortic dissection (Supportive), mode of inheritance: AD
- aortic aneurysm, familial thoracic 9 (Strong), mode of inheritance: AD
- familial thoracic aortic aneurysm and aortic dissection (Moderate), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Aortic aneurysm, familial thoracic 9 | AD | Cardiovascular | Individual have been described with aortic dilatation and arrhthymias, and awareness may allow surveillance and early medical and/or surgical management, which may reduce morbidity and mortality | Cardiovascular | 25434006 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (208 variants)
- Cardiovascular_phenotype (113 variants)
- not_specified (18 variants)
- Aortic_aneurysm,_familial_thoracic_9 (13 variants)
- MFAP5-related_disorder (13 variants)
- Familial_thoracic_aortic_aneurysm_and_aortic_dissection (3 variants)
- Isolated_thoracic_aortic_aneurysm (1 variants)
- Connective_tissue_disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MFAP5 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000003480.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 46 | 49 | ||||
missense | 98 | 14 | 112 | |||
nonsense | 8 | |||||
start loss | 1 | 1 | 2 | |||
frameshift | 7 | |||||
splice donor/acceptor (+/-2bp) | 9 | |||||
Total | 0 | 6 | 121 | 60 | 0 |
Highest pathogenic variant AF is 0.0000205234
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MFAP5 | protein_coding | protein_coding | ENST00000359478 | 9 | 25543 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00506 | 0.971 | 125716 | 0 | 31 | 125747 | 0.000123 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.322 | 96 | 105 | 0.912 | 0.00000619 | 1123 |
Missense in Polyphen | 44 | 44.935 | 0.97919 | 460 | ||
Synonymous | -0.600 | 39 | 34.5 | 1.13 | 0.00000190 | 323 |
Loss of Function | 1.97 | 6 | 14.0 | 0.430 | 7.91e-7 | 147 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000908 | 0.000907 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000223 | 0.000217 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000537 | 0.0000527 |
Middle Eastern | 0.000223 | 0.000217 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May play a role in hematopoiesis. In the cardiovascular system, could regulate growth factors or participate in cell signaling in maintaining large vessel integrity (By similarity). Component of the elastin-associated microfibrils (PubMed:8557636). {ECO:0000250|UniProtKB:Q9QZJ6, ECO:0000269|PubMed:8557636}.;
- Disease
- DISEASE: Aortic aneurysm, familial thoracic 9 (AAT9) [MIM:616166]: A disease characterized by permanent dilation of the thoracic aorta usually due to degenerative changes in the aortic wall. It is primarily associated with a characteristic histologic appearance known as 'medial necrosis' or 'Erdheim cystic medial necrosis' in which there is degeneration and fragmentation of elastic fibers, loss of smooth muscle cells, and an accumulation of basophilic ground substance. {ECO:0000269|PubMed:25434006}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- MFAP5-mediated ovarian cancer cell motility and invasiveness;Extracellular matrix organization;Molecules associated with elastic fibres;Elastic fibre formation;Notch signaling pathway
(Consensus)
Recessive Scores
- pRec
- 0.103
Intolerance Scores
- loftool
- 0.511
- rvis_EVS
- -0.34
- rvis_percentile_EVS
- 30.07
Haploinsufficiency Scores
- pHI
- 0.736
- hipred
- Y
- hipred_score
- 0.742
- ghis
- 0.584
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mfap5
- Phenotype
- skeleton phenotype; immune system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype;
Gene ontology
- Biological process
- extracellular matrix organization;definitive hemopoiesis;supramolecular fiber organization
- Cellular component
- microfibril;extracellular region;collagen-containing extracellular matrix
- Molecular function
- extracellular matrix structural constituent